Myocardial bridging (MB) is a congenital coronary artery anomaly and an important cause of angina. The genetic basis of MB is currently unknown. This study used a whole-exome sequencing technique and analyzed genotypic differences. Eight coronary angiography-confirmed cases of severe MB and eight age- and sex-matched control patients were investigated. In total, 139 rare variants that are potentially pathogenic for severe MB were identified in 132 genes. Genes with multiple rare variants or co-predicted by ClinVar and CADD/REVEL for severe MB were collected, from which heart-specific genes were selected under the guidance of tissue expression levels. Functional annotation indicated significant genetic associations with abnormal skeletal muscle mass, cardiomyopathies, and transmembrane ion channels. Candidate genes were reviewed regarding the functions and locations of each individual gene product. Among the gene candidates for severe MB, rare variants in DMD, SGCA, and TTN were determined to be the most crucial. The results suggest that altered anchoring proteins on the cell membrane and intracellular sarcomere unit of cardiomyocytes play a role in the development of the missed trajectory of coronary vessels. Additional studies are required to support the diagnostic application of cardiac sarcoglycan and dystroglycan complexes in patients with severe MB.

Original languageEnglish
Article number1509
JournalJournal of Personalized Medicine
Issue number10
Publication statusPublished - Oct 2023


  • cardiovascular disease
  • DMD
  • genetic variant
  • myocardial bridging
  • SGCA
  • TTN
  • whole-exome sequencing

ASJC Scopus subject areas

  • Medicine (miscellaneous)


Dive into the research topics of 'Identification of Genetic Variants Associated with Severe Myocardial Bridging through Whole-Exome Sequencing'. Together they form a unique fingerprint.

Cite this